PARP1 and breast cancer: While it remains dogma that IR and genotoxic agents mediate their lethal effects via enhanced apoptosis, necrosis or mitotic catastrophe, Efimova et al. showed that for Breast cancer cell lines PARP inhibitors may have a significant impact by inducing senescence [111].